Aurobindo Pharma arm gets USFDA nod for Plerixafor injection

Aurobindo Pharma said Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news